Weight Watchers buys Sequence, will provide weightloss medicine like Wegovy
WeightWatchers – for greater than 60 years the usual bearer of weight-reduction plan and train applications for weight reduction – is stepping into the medicine enterprise.
The corporate is buying a year-old telehealth startup known as Sequence, which will give patrons the choice to request anti-obesity medicine together with their month-to-month membership.
The small print of exactly how the medical care will probably be built-in into the behavioral well being system have but to labored out, mentioned Gary Foster, WeightWatchers’ chief scientific officer.
However after the deal closes this spring, WeightWatchers’ members will get the choice to request a telehealth go to to debate medicine. If eligible, Sequence’s know-how will pace the method of making use of for insurance coverage protection for the medicine.
“As a model chief, we now have a accountability to … take a look at latest advances within the science and therapy of weight problems and take into consideration if and the way they slot in our WeightWatchers’ ecosystem,” Foster mentioned. “We determined this was one which was value incorporating.”
Weight problems skilled Dr. Caroline Apovian mentioned she’s skeptical weight reduction will be nicely managed with out an in-person bodily examination, however praised the transfer into medicine.
“Kudos to them for doing this,” mentioned Apovian, who co-directs the Middle for Weight Administration and Wellness at Brigham and Ladies’s Hospital.
A brand new class of medication has been proven to assist individuals shed 15% to twenty% of their extra weight, the type of weight reduction solely attainable earlier than with bariatric surgical procedure.
“Way of life (change) is essential however it’s not going to assist individuals hold the load off and that is the important thing,” mentioned Apovian, who serves on the scientific advisory board of Novo Nordisk, which makes one of many new medicine.
Particulars of the deal
WeightWatchers will purchase Sequence for a complete of $132 million in a deal scheduled to be finalized this spring, in keeping with a joint information launch from the 2 firms.
Sequence, which launched in late 2021, had about $25 million in annual income from roughly 24,000 members as of final month. It gives an automatic preapproval course of to assist sufferers get protection for weight-loss drugs.
“For individuals who have insurance coverage protection, you can verify insurance coverage protection briefly order,” which will be difficult for a lot of medical places of work to deal with and has been a significant roadblock for accessing drugs, Foster mentioned.
At the moment, solely about 20% to 30% of personal insurance policy cowl weight-loss drugs and authorities applications don’t, Apovian mentioned.
The drug Wegovy (generically known as semaglutide), which will help individuals lose as a lot as 15% of their physique weight, prices about $1,300 a month. Mounjaro (tirzepatide), a $1,000-a-month diabetes medicine being examined for weight reduction, has proven it will possibly assist individuals lose about 20%.
Foster mentioned he additionally was impressed with how Sequence’s clients spoke concerning the high quality of the service and the way simple it was for them to entry care. The corporate has a restricted historical past and did primarily no advertising and marketing, he mentioned, however nonetheless managed to build up greater than 20,000 members.
“We’re at all times searching for how we will higher serve individuals with weight administration that’s scalable, science-based and efficient,” Foster mentioned.
Weight-loss drugs aren’t for everybody, he mentioned, however for the individuals for whom they’re acceptable “we wish to make it possible for course of will get executed nicely.”
Why provide weight reduction drugs now?
In one examine of 150 WeightWatchers members, contributors misplaced about 6% of their physique weight after six months, with one-third of probably the most energetic members shedding at the least 10%.
The brand new era of medicines, which manipulate pure hormones that regulate fullness, can result in a lot higher weight reduction.
Foster described this class of medication, known as GLP-1 agonists, as “a major inflection level within the therapy of weight problems.”
Whereas most individuals who drop some weight by weight-reduction plan and train regain the load, drugs are anticipated to be taken indefinitely to maintain kilos from creeping again.
“This isn’t a short-term repair,” mentioned Dr. Christopher Nonetheless, an weight problems drugs skilled and director of the Geisinger Weight problems Institute. “When you cease these drugs, you are taking away that barrier of urge for food and your urge for food comes again and the load comes again.”
WeightWatchers’ buy is “an amazing concept,” in keeping with Dr. Yoni Freedhoff, a Canadian weight-loss specialist, who takes some funding from Novo Nordisk.
“Proper now, we now have a world that treats weight problems like a illness of willpower and a healthcare system that is not educated within the medical administration of weight problems,” he mentioned.
Prior to now, WeightWatchers has contributed to the false notion that life-style change can result in enduring weight reduction for many individuals, Freedhoff mentioned, whereas in actuality 1000’s of genes and hormones undermine weight reduction efforts. “Fortunately, we’re lastly in an period of protected, helpful, tolerable drugs that may result in long-term clinically significant change.”
The medicine are supposed for use together with a nutritious diet and common train, so WeightWatchers’ conventional plan will assist people who find themselves eligible for and select to make use of medicine, Foster mentioned. As individuals lose substantial quantities of weight they’re anticipated to lose some muscle, so train will stay essential.
“We’re not going away and we’ll proceed to assist individuals whether or not drugs are a part of their journey or not,” he mentioned.
What does WeightWatchers do?
For a month-to-month membership price starting from about $23 to $45, WeightWatchers offers some extent system associated to meals and train, a digital app, branded meals and objects and in-person and digital workshops.
The corporate has been struggling financially lately. Its inventory, which bought for over $100 a share as lately as June 2018 closed on Monday at below $4 a share.
Advocates have criticized WeightWatchers for giving individuals false hope about their capacity to lose and hold off weight by weight-reduction plan and train, which has been proven ineffective long-term for the overwhelming majority of individuals.
“Weight Watchers has made their fortune fomenting fatphobia, co-opting physique positivity, and promoting a product that nearly by no means works,” advocate Ragen Chastain mentioned in an e-mail. “The truth that an organization that’s so morally bankrupt that it has been placing income over individuals since its inception may achieve the power to prescribe drugs with harmful uncomfortable side effects is horrifying.”
Dr. David Ludwig, an weight problems specialist at Boston Youngsters’s Hospital, mentioned he does not see medicine as the answer to weight problems, which now consists of greater than 40% of Individuals.
However the newer drugs will be very efficient at serving to individuals drop some weight.
“They’re in a category by themselves in comparison with prior choices and there is quite a lot of pleasure about them,” Ludwig mentioned.
Dig deeper
Contact Karen Weintraub at kweintraub@usatoday.com.
Well being and affected person security protection at USA TODAY is made attainable partly by a grant from the Masimo Basis for Ethics, Innovation and Competitors in Healthcare. The Masimo Basis doesn’t present editorial enter.
